Stocks To Watch: American Capital, Ltd. (ACAS), Pacific Biosciences of California, Inc. (PACB), CVS Health Corporation (CVS)

American Capital, Ltd. (ACAS) opening the day at $17.33. The company has seen its stock increase in value by 24.44% so far this year. The stock was down close to -0.98% on active volume in last trading session and closed at $17.16 per share. After the recent fall, the stock is currently holding -3.27% below its 52 week high of $17.74 and 41.35% above its 12-month low of $12.14. The shares are up by over 2.02% in the last three months, and the RSI indicator value of 44.13 is neither bullish nor bearish, tempting investors to stay on the sidelines.

American Capital, Ltd. is a business development company specializing in management and employee buyouts, subordinated debt, leveraged finance, mezzanine, acquisition, recapitalization, middle market, early venture, mature, industry consolidation, and growth capital investments. The firm seeks to invest in senior debt mezzanine, unitranche, and equity financing for buyouts of private equity firms and direct in private and public companies. It also invests in special situations and in government. In special situations, the firm invests in troubled situations and in distressed situations. The firm also considers smaller investments as add-on acquisitions for existing portfolio companies. In this area, it invests in acquisitions of true turnarounds, 363 auctions, portfolio add-on acquisitions, operationally challenged companies; financings in exit, ABL loans, second lien refinance, and direct lending to distressed companies. The firm invests in manufacturing, services, and distribution companies with a special focus on energy sector. The firm also invests in infrastructure and structured products. The firm also invests in business services, consumer products and services, industrial, healthcare and food companies. The firm prefers to invest in Information Technology focusing on Custom information technology solutions, Technology and software enabling headcount reduction, and Technology and software enabling cost reductions in conducting transactions with or within government. The firm also invests in digital media and entertainment, internet and consumer related, communications, mobile and wireless, security and data center infrastructure, software and services, semiconductor, and other innovative technologies. The firm also invests in a variety of industry sectors, including life science services, medical device, medical tools and equipment, and healthcare services, among others. In energy production sector, the firm invests in lower risk oil and gas exploration, production and development; natural gas liquids; coal mining and coal-fired generation; uranium mining and nuclear-fired generation; wind-powered generation; and solar-powered generation. In energy transmission sector, the firm invests in oil and gas pipelines; LNG tankers and regasification facilities; and power transmission. In energy distribution sector, it targets propane distribution; gas distribution; electricity distribution. In energy services sector, the firm invests in oil and gas services and utility services. The firm also targets investments in companies that provide services or products to federal, state or local governments. It seeks to invest in human resources/benefit administration, outsourcing, transaction processing, engineering and construction, logistics, original equipment manufacturers – homeland security and component, aftermarket parts and supplies, and technology. It also invests in real estate and insurance. It invests as lead or participative investor and also makes equity co-investments. The firm seeks to invest globally focusing on Middle East, North Africa, South Asia, Mid-Atlantic, New England, North East Unites States, Canada, Central America & Mexico, and Caribbean. The firm and its affiliates invest between $10 million to $750 million per company in North America and €10 ($13.34 million) to €400 million ($533.99 million) per company in Europe. The firm’s investment range is between $5 million and $25 million and higher depending on the opportunity. The firm targets new investments with at least $10 million in EBITDA and enterprise values of typical transaction from $20 million and $500 million. The firm invests senior debt, subordinated debt and equity allows us to provide one-stop financing up to $500 million. The firm also has the resources to deploy over $100 million into high growth later stage companies. In special situations group, the firm invests between $20 million and $750 million per transaction in a variety of investments, including: buyouts operational turnarounds, corporate orphans and carve-outs, complex management buyouts, financings dip financings, exit financings, and mezzanine financings for sponsored buyouts. In buyouts, the firm invests in companies having Enterprise Value of up to $1600 million. In federal, state and local government, the firm invests between $10 million and $500 million in a single transaction. The firm prefers to be a majority or minority investor and makes direct minority investments of subordinated debt, senior debt and equity in middle market private and public companies. The firm prefers to take minority ownership position of up to 49%. American Capital, Ltd., formerly known as American Capital Strategies, Ltd., was founded in 1986 and is based in Bethesda, Maryland with additional offices in United States, Europe, Africa, and Asia.

Pacific Biosciences of California, Inc. (PACB) continued its downward trend with the stock declining -43.62% or $-3.01 to close the day at $3.89 on light trading volume of 10.8M shares, compared to its three month average trading volume of 984.85K. The Menlo Park California 94025 based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -61.56%, compared to the industry which has dropped -6.49% over the same period. With RSI of 13.74, the stock should still continue to rise and get closer to its one year target estimate of $11.67, making it a hold for now.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company’s single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes biochemical sequencing reactions. The company also provides consumable products, including sealed and packaged SMRT cells, as well as various reagent kits, such as template preparation, binding, and sequencing kits to run the PacBio RS II or Sequel System. Its customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. The company markets its products through a direct sales force in North America and Europe, as well as primarily through distributors in Asia. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.

CVS Health Corporation (CVS) dropped $-0.67 to close the day at a new closing price of $78.29, a -0.85% decrease in value from its previous closing price that moved the stock 12.97% above its 52 week low of $69.3. A total of 10.62M shares exchanged hands during the day compared with its three month average trading volume of 8.4M. The stock, which fluctuated between $76.11 and $79.24 during the day, currently situated -25.92% below its 52 week high. The stock is up by 4.33% in the past one month and down by -12.7% over the past three months. With a one year target estimate of $86.79 and RSI of 48.21, the stock still has upside potential, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

3 Stocks to Watch For: JetBlue Airways Corporation (JBLU), CVS Health Corporation (CVS), Corning Incorporated (GLW)

JetBlue Airways Corporation (JBLU) saw its value decrease by -1.69% as the stock dropped $-0.38 to finish the day at a closing price of $22.15. The stock was higher in trading and has fluctuated between $14.76-$23.8 per share for the past year. The shares are up by 26.35% in the past three months and up by 34.49% over the past six months. It is currently trading 5.44% above its 20 day moving average and 15.52% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $23.31 a share over the next twelve months. The current relative strength index (RSI) reading is 67.44.The technical indicator lead us to believe there will be no major movement any time soon, hold.

JetBlue Airways Corporation, a passenger carrier company, provides air transportation services. As of December 31, 2014, the company operated a fleet of 25 Airbus A321 aircrafts, 130 Airbus A320 aircrafts, and 60 Embraer E190 aircrafts. It also served 93 destinations in 28 states in the United States, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, and 19 countries in the Caribbean and Latin America. JetBlue Airways Corporation was founded in 1998 and is based in Long Island City, New York.

CVS Health Corporation (CVS) shares were down in last trading by -1.48% to $78.96. It experienced lighter than average volume on day. The stock decreased in value by almost -1.95% over the past week and grew 3.89% in the past month. It is currently trading -2.63% below its 50 day moving average and -14.88% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -25.28% decrease in value from its one year high of $106.67. The RSI indicator value of 50.96, lead us to believe that it is a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Corning Incorporated (GLW) traded within a range of $24.31 to $24.62 after opening the day at $24.45. The company has seen its stock increase in value by 36.63% so far this year. The stock was down close to -0.49% on light volume in last trading session and closed at $24.34 per share. After the recent fall, the stock is currently holding -3.98% below its 52 week high of $25.34 and 54.84% above its 12-month low of $16.13. The shares are up by over 8.37% in the last three months, and the RSI indicator value of 57.33 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Corning Incorporated manufactures and sells specialty glasses, ceramics, and related materials worldwide. The company operates through five segments: Display Technologies, Optical Communications, Environmental Technologies, Specialty Materials, and Life Sciences. The Display Technologies segment manufactures glass substrates for liquid crystal displays (LCDs) used in LCD televisions, notebook computers, and flat panel desktop monitors. The Optical Communications segment manufactures optical fiber and cable; and hardware and equipment products comprising cable assemblies, fiber optic hardware and connectors, optical components and couplers, closures, network interface devices, and other accessories. This segment also offers subscriber demarcation, connection and protection devices, passive solutions, and outside plant enclosures; and coaxial RF interconnects for the cable television industry and microwave applications. The Environmental Technologies segment manufactures ceramic substrates and filter products for emissions control in mobile and stationary, and gasoline and diesel applications. The Specialty Materials segment manufactures products that provide approximately 150 material formulations for glass, glass ceramics, and fluoride crystals. The Life Sciences segment manufactures and supplies scientific laboratory products consisting of consumables, such as plastic vessels, specialty surfaces, and media, as well as general labware and equipment for cell culture research, bioprocessing, genomics, drug discovery, microbiology, and chemistry. It also engages in a pharmaceutical glass vessel and a tubing business; and precision materials’ non-LCD business, as well as precision laser cutting/shaping technologies, and flow reactors and adjacency businesses for glass. The company was formerly known as Corning Glass Works and changed its name to Corning Incorporated in April 1989. Corning Incorporated was founded in 1851 and is headquartered in Corning, New York.

 

Stocks Trending Alert: QUALCOMM Incorporated (QCOM), CVS Health Corporation (CVS), Endologix, Inc. (ELGX)

QUALCOMM Incorporated (QCOM) saw its value increase by 1.27% as the stock gained $0.87 to finish the day at a closing price of $69.34. The stock was lighter in trading and has fluctuated between $42.24-$71.62 per share for the past year. The shares are up by 13.46% in the past three months and up by 32.27% over the past six months. It is currently trading 3.51% above its 20 day moving average and 3.75% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $73.36 a share over the next twelve months. The current relative strength index (RSI) reading is 61.02.The technical indicator lead us to believe there will be no major movement any time soon, hold.

QUALCOMM Incorporated develops, designs, manufactures, and markets digital communications products and services in China, South Korea, Taiwan, the United States, and internationally. The company operates through three segments: Qualcomm CDMA Technologies (QCT); Qualcomm Technology Licensing (QTL); and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on code division multiple access (CDMA), orthogonal frequency division multiple access (OFDMA), and other technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses or provides rights to use portions of its intellectual property portfolio, which include various patent rights useful in the manufacture and sale of certain wireless products comprising products implementing CDMA2000, WCDMA, CDMA TDD, and/or LTE standards, as well as their derivatives. The QSI segment invests in early-stage companies in various industries, including digital media, e-commerce, healthcare, and wearable devices for supporting the design and introduction of new products and services for voice and data communications. The company also develops and offers products for implementation of small cells; mobile health products and services; software products, and content and push-to-talk enablement services to wireless operators; and development, and other services and related products to the United States government agencies and their contractors. In addition, it licenses chipset technology and products for data centers. QUALCOMM Incorporated was founded in 1985 and is headquartered in San Diego, California.

CVS Health Corporation (CVS) shares were up in last trading by 0.53% to $80.15. It experienced lighter than average volume on day. The stock increased in value by almost 0.92% over the past week and grew 6.74% in the past month. It is currently trading -1.33% below its 50 day moving average and -13.67% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -24.16% decrease in value from its one year high of $106.67. The RSI indicator value of 54.57, lead us to believe that it is a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Endologix, Inc. (ELGX) opening the day at $5.98. The company has seen its stock decrease in value by -34.44% so far this year. The stock was down close to -5.81% on active volume in last trading session and closed at $6.49 per share. After the recent fall, the stock is currently holding -55.24% below its 52 week high of $14.49 and 4.34% above its 12-month low of $5.76. The shares are down by over -47.45% in the last three months, and the RSI indicator value of 25.94 is bullish. They are not pointing to a rebound in the stock. We should get in as it looks to have found a bottom.

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular repair (EVAR) products, including EVAR stent graft and catheter delivery system under the Powerlink, IntuiTrak, AFX, and VELA Proximal Endograft brand names. It also provides endovascular sealing (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which attach to the main body of its EVAR device, allowing physicians to customize it to fit the patient’s anatomy; and accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths. It sells its products through direct sales force, network of agents, and independent distributors or agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.

 

3 Notable Runners: JetBlue Airways Corporation (JBLU), CVS Health Corporation (CVS), Opko Health, Inc. (OPK)

JetBlue Airways Corporation (JBLU) failed to extend gains with the stock declining -1.28% or $-0.28 to close the day at $21.62 on higher than average trading volume of 6.62M shares, compared to its three month average trading volume of 6.32M. The Long Island City New York 11101 based company has been outperforming the regional airlines companies by 25.5634% for last three months and its recent gains have offset losses to -4.55% YTD, versus the regional airlines industry which is up 14.8% for the same period. The RSI of 66.39 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

JetBlue Airways Corporation, a passenger carrier company, provides air transportation services. As of December 31, 2014, the company operated a fleet of 25 Airbus A321 aircrafts, 130 Airbus A320 aircrafts, and 60 Embraer E190 aircrafts. It also served 93 destinations in 28 states in the United States, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, and 19 countries in the Caribbean and Latin America. JetBlue Airways Corporation was founded in 1998 and is based in Long Island City, New York.

CVS Health Corporation (CVS) had a light trading with around 6.61M shares changing hands compared to its three month average trading volume of 8.33M. The stock traded between $79.26 and $80.53 before closing at the price of $79.73 with -0.5% change on the day. The Woonsocket Rhode Island 02895 based company is currently trading 15.05% above its 52 week low of $69.3 and -24.55% below its 52 week high of $106.67. Both the RSI indicator and target price of 53.74 and $86.79 respectively, lead us to believe that it should be put on hold over the coming weeks.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Opko Health, Inc. (OPK) opening the day at $11.06. The company has seen its stock increase in value by 15.92% so far this year. The stock was up close to 6.2% on active volume in last trading session and closed at $11.65 per share. After the recent gain, the stock is currently holding -1.69% below its 52 week high of $11.85 and 63.62% above its 12-month low of $7.12. The shares are up by over 16.04% in the last three months, and the RSI indicator value of 68.33 is neither bullish nor bearish, tempting investors to stay on the sidelines.

OPKO Health, Inc., a biopharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies in the United States, Ireland, Chile, Spain, Israel, and Mexico. Its diagnostics business operates Bio-Reference Laboratories, a clinical laboratory that offers comprehensive laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units. The Bio-Reference Laboratories also provides core genetic testing and leverages products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. The company’s pharmaceutical segment features Rayaldee, a treatment for secondary hyperparathyroidism in stage 3-4 chronic kidney disease patients with vitamin D deficiency and VARUBI for chemotherapy-induced nausea and vomiting. Its biologics business engages in developing and commercializing hGH-CTP, a recombinant human growth hormone product under development for the treatment of growth hormone deficiency, and developing Factor VIIa drug for hemophilia using the carboxl terminal peptide technology. The company was incorporated in 1991 and is headquartered in Miami, Florida.

 

Stocks in Review: Yahoo! Inc. (YHOO), CVS Health Corporation (CVS), Southwest Airlines Co. (LUV)

Yahoo! Inc. (YHOO) opening the day at $41.52. The company has seen its stock increase in value by 25.56% so far this year. The stock was up close to 0.85% on light volume in last trading session and closed at $41.76 per share. After the recent gain, the stock is currently holding -7.03% below its 52 week high of $44.92 and 59.69% above its 12-month low of $26.15. The shares are down by over -3.91% in the last three months, and the RSI indicator value of 56.64 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Yahoo! Inc., together with its subsidiaries, provides search and display advertising services on Yahoo properties and affiliate sites worldwide. The company offers Yahoo Search that serves as a guide for users to discover information on the Internet; Yahoo Mail, which connects users to the people and content; and Yahoo Messenger, an instant messaging service, which enables users to connect, communicate, and share experiences in real-time. It also provides digital content products, including Yahoo News, which gives users to discover, consume, and engage around the news, content, and video; Yahoo Sports, which serves audiences of sports enthusiasts; Yahoo Finance that offers a range of financial data, information, and tools; Yahoo Lifestyle to engage users passionate about style and fashion; and Tumblr, which provides a Web platform and mobile applications on iOS and android to create, share, and curate content, as well as Tumblr messaging that enables users to engage with other users that share their same interests and passions. In addition, the company provides advertiser products, such as Yahoo Gemini, a marketplace for search and native advertising; and BrightRoll, which offers a suite of media-agnostic tools to enable advertisers, publishers, and partners connect with users across ad formats and devices. Further, it offers advertising formats; and digital advertising products, such as Yahoo native, Yahoo video, Yahoo premium, and Yahoo audience ads. Additionally, the company offers Yahoo Mobile Developer suite consisting of Flurry Analytics, Yahoo App Publishing, Yahoo App Marketing, and Tumblr In-App Sharing tools to measure, monetize, advertise, and improve their apps. Yahoo! Inc. was founded in 1994 and is headquartered in Sunnyvale, California.

CVS Health Corporation (CVS) managed to rebound with the stock climbing 2.59% or $2.02 to close the day at $80.13 on light trading volume of 6.72M shares, compared to its three month average trading volume of 8.32M. The Woonsocket Rhode Island 02895 based company has been underperforming the health care plans group over the past 52 weeks, with the stock losing -13.89%, compared to the industry which has advanced 9.89% over the same period. With RSI of 55.55, the stock should still continue to rise and get closer to its one year target estimate of $86.79, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Southwest Airlines Co. (LUV) gained $0.19 to close the day at a new closing price of $49.79, a 0.38% increase in value from its previous closing price that moved the stock 47.94% above its 52 week low of $33.96. A total of 6.7M shares exchanged hands during the day compared with its three month average trading volume of 7.7M. The stock, which fluctuated between $49.22 and $50.68 during the day, currently situated -0.38% below its 52 week high. The stock is up by 17.76% in the past one month and up by 31.93% over the past three months. With a one year target estimate of $51.5 and RSI of 73.71, the stock still has upside potential, making it a sell for now.

Southwest Airlines Co. operates passenger airlines that provide scheduled air transportation services in the United States and near-international markets. As of December 31, 2015, it operated 704 Boeing 737 aircraft. The company served 97 destinations in 40 states, the District of Columbia, and the Commonwealth of Puerto Rico, as well as 7 near-international countries, including Mexico, Jamaica, The Bahamas, Aruba, the Dominican Republic, Costa Rica, and Belize. It also sells frequent flyer points and related services to business partners participating in the Rapid Rewards frequent flyer program, including car rental agencies, hotels, restaurants, and retailers. The company was founded in 1967 and is headquartered in Dallas, Texas.

 

Investor’s Alert: CVS Health Corporation (CVS), J. C. Penney Company, Inc. (JCP), Ciena Corporation (CIEN)

CVS Health Corporation (CVS) failed to extend gains with the stock declining -3.01% or $-2.42 to close the day at $78.11 on lower than average trading volume of 16.11M shares, compared to its three month average trading volume of 8.18M. The Woonsocket Rhode Island 02895 based company has been outperforming the health care plans companies by -14.2971% for last three months and its recent losses have pulled the stock down -18.66% YTD, versus the health care plans industry which is up 6.16% for the same period. The RSI of 49.74 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

  1. C. Penney Company, Inc. (JCP) had a light trading with around 15.24M shares changing hands compared to its three month average trading volume of 15.32M. The stock traded between $10.37 and $10.74 before closing at the price of $10.56 with 1.15% change on the day. The Plano Texas 75024 based company is currently trading 76% above its 52 week low of $6 and -11.93% below its 52 week high of $11.99. Both the RSI indicator and target price of 70.42 and $11.79 respectively, lead us to believe that it could drop over the coming weeks.
  2. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., sells merchandise through department stores in the United States. The company sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings, as well as provides various services, including styling salon, optical, portrait photography, and custom decorating. As of January 30, 2016, it operated approximately 1,021 department stores in 49 states and Puerto Rico. The company also sells its products through its Website, jcpenney.com. J. C. Penney Company, Inc. was founded in 1902 and is based in Plano, Texas.

Ciena Corporation (CIEN) traded within a range of $22.78 to $24.99 after opening the day at $23.13. The company has seen its stock increase in value by 20.2% so far this year. The stock was up close to 15.14% on active volume in last trading session and closed at $24.87 per share. After the recent gain, the stock is currently holding 1.34% above its 52 week high of $24.99 and 59.22% above its 12-month low of $15.62. The shares are up by over 14.82% in the last three months, and the RSI indicator value of 71.9 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.

Ciena Corporation provides equipment, software, and services that support the transport, switching, aggregation, service delivery, and management of voice, video, and data traffic on communications networks worldwide. The company’s Converged Packet Optical segment offers networking solutions optimized for the convergence of coherent optical transport, OTN switching, and packet switching. Its products comprise the 6500 Packet-Optical Platform, 5430 Reconfigurable Switching System, CoreDirector Multiservice Optical Switches, and OTN configuration for the 5410 Reconfigurable Switching System. This segment also sells operating system software and enhanced software features embedded in each of these products. Its Packet Networking segment provides the 3000 family of service delivery switches and service aggregation switches, the 5000 family of service aggregation switches, 8700 Packetwave Platform, and the Ethernet packet configuration for the 5410 Service Aggregation Switch. The company’s Optical Transport segment transports voice, video, and data traffic at high transmission speeds. Its principal products include the 4200 Advanced Services Platform, Corestream Agility Optical Transport System, 5100/5200 Advanced Services Platform, Common Photonic Layer, and 6100 Multiservice Optical Platform. Its Software and Services segment offers network management solutions, including the OneControl Unified Management System, ON-Center Network & Service Management Suite, Ethernet Services Manager, Optical Suite Release, and Planet Operate; Blue Planet software platform; and SDN Multilayer WAN Controller and its related applications. This segment also provides consulting and network design, installation and deployment, maintenance support, and training services. The company sells its products through direct and indirect sales channels to network operators. Ciena Corporation was founded in 1992 and is headquartered in Hanover, Maryland.

Stocks in Focus: Staples, Inc. (SPLS), Pioneer Energy Services Corp. (PES), CVS Health Corporation (CVS)

Staples, Inc. (SPLS) had a light trading with around 10.77M shares changing hands compared to its three month average trading volume of 7.9M. The stock traded at the price of $9.95 with 0.61% change on the day. The Framingham Massachusetts 01701 based company is currently trading 37.43% above its 52 week low of $7.24 and -15.03% below its 52 week high of $11.37. Both the RSI indicator and target price of 74.35 and $9.64 respectively, lead us to believe that it could drop over the coming weeks.

Staples, Inc., together with its subsidiaries, operates office products superstores. It operates in three segments: North American Stores & Online, North American Commercial, and International Operations. The company offers a range of office supplies, business technology products, facility and breakroom supplies, computers and mobility products, and office furniture under the Staples, Quill, and other proprietary brands. It also provides copy and print services, as well as technology services. The company sells and delivers office products and services directly to businesses and consumers through its Staples.com and Staples.ca, and Quill.com Websites, as well as through retail stores, and Internet and direct mail catalogs. As of January 30, 2016, it operated approximately 1,907 retail stores; and 104 distribution and fulfillment centers in the United States and internationally. The company was founded in 1985 and is based in Framingham, Massachusetts.

Pioneer Energy Services Corp. (PES) continued its upward trend with the stock climbing -15.67% or $0.45 to close the day at $6.7 on light trading volume of 10.59M shares, compared to its three month average trading volume of 789.90K. The San Antonio Texas 78209 based company has been outperforming the oil & gas drilling & exploration group over the past 52 weeks, with the stock gaining 135.42%, compared to the industry which has advanced 59.98% over the same period. With RSI of 61.33, the stock should still continue to rise and get closer to its one year target estimate of $4.68, making it a hold for now.

Pioneer Energy Services Corp. provides land-based drilling and production services to oil and gas exploration and production companies in the United States and Colombia. The company’s Drilling Services segment offers contract land drilling services in Texas, North Dakota, Appalachia, and Colombia. As of December 31, 2015, this segment operated a fleet of 31 drilling rigs. Its Production Services segment provides well servicing, wireline services, and coiled tubing services to exploration and production companies in the onshore oil and gas producing regions in the Mid-Continent and Rocky Mountain states; and in the onshore and offshore Gulf Coast. As of December 31, 2015, this segment operated a fleet of 114 rigs with 550 horsepower and 11 rigs with 600 horsepower; 125 wireline units; and 12 onshore and five offshore coiled tubing units. The company was formerly known as Pioneer Drilling Company and changed its name to Pioneer Energy Services Corp. in 2012. Pioneer Energy Services Corp. was founded in 1968 and is headquartered in San Antonio, Texas.

CVS Health Corporation (CVS) shares were up in last trading by 1.4% to $80.53. It experienced higher than average volume on day. The stock increased in value by almost 4.73% over the past week and fell -3.43% in the past month. It is currently trading -1.8% below its 50 day moving average and -13.57% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -23.8% decrease in value from its one year high of $106.67. The RSI indicator value of 59.13, lead us to believe that it is a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Stocks in Focus: Johnson Controls International plc (JCI), CVS Health Corporation (CVS), The Dow Chemical Company (DOW)

Johnson Controls International plc (JCI) had a active trading with around 9.8M shares changing hands compared to its three month average trading volume of 6.52M. The stock traded between $43.41 and $44.48 before closing at the price of $44.1 with -1.19% change on the day. The Cork Cork T12 X8N6 based company is currently trading 54.76% above its 52 week low of $28.94 and -9.94% below its 52 week high of $48.97. Both the RSI indicator and target price of 46.03 and $50.07 respectively, lead us to believe that it should be put on hold over the coming weeks.

Johnson Controls International plc operates as a diversified technology and multi industrial company worldwide. The company operates through Buildings and Power Solutions segments. It designs, produces, markets, and installs heating, ventilating, and air conditioning (HVAC) systems, building management systems, controls, and security and mechanical equipment. The company also provides residential air conditioning and heating systems, and industrial refrigeration products, as well as technical and energy management consulting services. In addition, it designs, sells, installs, services, and monitors electronic security systems, and fire detection and suppression systems; and manufactures and sells intrusion security products, anti-theft devices, breathing apparatus, and access control and video management systems for commercial, industrial, retail, residential, small business, institutional, and governmental customers. Further, the company produces and supplies lead-acid automotive batteries for passenger cars, light trucks, and utility vehicles, as well as advanced battery technologies to power start-stop, hybrid, and electric vehicles. It offers its lead-acid automotive batteries to automotive original equipment manufacturers and the general vehicle battery aftermarket. The company was formerly known as Johnson Controls, Inc. and changed its name to Johnson Controls International plc in September 2016. Johnson Controls International plc was founded in 1885 and is headquartered in Cork, Ireland.

CVS Health Corporation (CVS) continued its upward trend with the stock climbing 1.83% or $1.43 to close the day at $79.42 on active trading volume of 9.8M shares, compared to its three month average trading volume of 7.98M. The Woonsocket Rhode Island 02895 based company has been underperforming the health care plans group over the past 52 weeks, with the stock losing -16.07%, compared to the industry which has advanced 9.67% over the same period. With RSI of 55.71, the stock should still continue to rise and get closer to its one year target estimate of $88.02, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

The Dow Chemical Company (DOW) shares were up in last trading by 0.29% to $56.22. It experienced higher than average volume on day. The stock increased in value by almost 4.13% over the past week and grew 5.82% in the past month. It is currently trading 4.89% above its 50 day moving average and 8.69% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -0.55% decrease in value from its one year high of $57.1. The RSI indicator value of 67.57, lead us to believe that it is a hold for now.

The Dow Chemical Company manufactures and supplies products that are used primarily as raw materials in the manufacture of customer products and services worldwide. It operates through Agricultural Sciences, Consumer Solutions, Infrastructure Solutions, Performance Materials & Chemicals, and Performance Plastics segments. The Agricultural Sciences segment provides crop protection and seed/plant biotechnology products and technologies, urban pest management solutions, and healthy oils. The Consumer Solutions segment offers semiconductors and organic light-emitting diodes, and adhesives and foams used by the transportation industry; and cellulosics and other polymers for innovative pharmaceutical formulations and food solutions. It serves automotive, electronics and entertainment, food and pharmaceuticals, and personal and home care products markets. The Infrastructure Solutions segment provides architectural and industrial coatings, construction material ingredients, building insulation, adhesives, and microbial protection products for the oil and gas industry; water technologies; monomers; and silicone and silicone products. The Performance Materials & Chemicals segment offers chlorine and caustic soda; industrial solutions; and propylene oxides, propylene glycols, polyether polyols, and aromatic isocyanates. The Performance Plastics segment provides elastomers, polyolefin plastomers, and ethylene propylene diene monomer elastomers; wire and cable insulation, semiconductive, and jacketing compound solutions, as well as bio-based plasticizers; acrylics, polyethylene, polyolefin emulsions, and polyolefin plastomers; and ethylene, propylene, benzene, butadiene, cumene, octene, aromatics co-products, and crude c4. The company was founded in 1897 and is headquartered in Midland, Michigan.

 

Stocks in Focus: Abbott Laboratories (ABT), Delta Air Lines, Inc. (DAL), CVS Health Corporation (CVS)

Abbott Laboratories (ABT) had a active trading with around 9.51M shares changing hands compared to its three month average trading volume of 8.37M. The stock traded between $37.99 and $38.45 before closing at the price of $38.43 with 1.4% change on the day. The Abbott Park Illinois 60064 based company is currently trading 8.75% above its 52 week low of $36 and -15.54% below its 52 week high of $46.22. Both the RSI indicator and target price of 41.89 and $47.38 respectively, lead us to believe that it should be put on hold over the coming weeks.

Abbott Laboratories manufactures and sells health care products worldwide. The company’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière’s disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company’s Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. The company has strategic alliance with Fonterra. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois.

Delta Air Lines, Inc. (DAL) failed to extend gains with the stock declining -1.01% or $-0.49 to close the day at $47.82 on active trading volume of 9.24M shares, compared to its three month average trading volume of 10.23M. The Atlanta Georgia 30354 based company has been underperforming the major airlines group over the past 52 weeks, with the stock losing -2.34%, compared to the industry which has dropped -1.16% over the same period. With RSI of 62.94, the stock should still continue to rise and get closer to its one year target estimate of $0, making it a hold for now.

Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. The company operates through two segments, Airline and Refinery. Its route network is centered around a system of hubs, international gateways, and airports in Amsterdam, Atlanta, Boston, Detroit, London-Heathrow, Los Angeles, Minneapolis-St. Paul, New York-LaGuardia, New York-JFK, Paris-Charles de Gaulle, Salt Lake City, Seattle, and Tokyo-Narita. The company sells its tickets through various distribution channels, including delta.com and mobile, telephone reservations, traditional brick and mortar, and online travel agencies. It also provides aircraft maintenance, repair, and overhaul services; staffing, and professional security and training services, as well as aviation solutions to third parties; vacation packages to third-party consumers; and aircraft charters, and aircraft management and programs. As of February 3, 2016, the company operated a fleet of approximately 800 aircrafts. Delta Air Lines, Inc. was founded in 1924 and is headquartered in Atlanta, Georgia.

CVS Health Corporation (CVS) shares were up in last trading by 0.48% to $77.99. It experienced higher than average volume on day. The stock increased in value by almost 4.29% over the past week and fell -4.39% in the past month. It is currently trading -5.41% below its 50 day moving average and -16.45% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -26.2% decrease in value from its one year high of $106.67. The RSI indicator value of 50.34, lead us to believe that it is a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Momentum Stocks in Focus: NVIDIA Corporation (NVDA), Denbury Resources Inc. (DNR), CVS Health Corporation (CVS)

NVIDIA Corporation (NVDA) managed to rebound with the stock climbing 0.92% or $0.81 to close the day at $88.45 on active trading volume of 11.95M shares, compared to its three month average trading volume of 11.34M. The Santa Clara California 95050 based company has been outperforming the semiconductor – specialized group over the past 52 weeks, with the stock gaining 175.36%, compared to the industry which has advanced 43.62% over the same period. With RSI of 59.47, the stock should still continue to rise and get closer to its one year target estimate of $85.02, making it a hold for now.

NVIDIA Corporation operates as a visual computing company worldwide. It operates in two segments, GPU and Tegra Processor. The GPU segment offers processors, which include GeForce for PC gaming; Quadro for design professionals working in computer-aided design, video editing, special effects, and other creative applications; Tesla for deep learning, accelerated computing, and general purpose computing; and GRID for cloud-based streaming on gaming devices. The Tegra Processor segment provides processors that integrate a computer onto a single chip under the Tegra brand name; DRIVE automotive computers, which offer supercomputing capabilities; and tablet and portable devices for mobile gaming under the SHIELD name. The company’s products are used in gaming, professional visualization, datacenter, and automotive markets. It sells its products primarily to original equipment manufacturers, original design manufacturers, system builders, motherboard manufacturers, add-in board manufacturers, and retailers/distributors. NVIDIA Corporation was founded in 1993 and is headquartered in Santa Clara, California.

Denbury Resources Inc. (DNR) retreated with the stock falling -1.85% or $-0.07 to close at $3.72 on active trading volume of 11.92M compared its three months average trading volume of 11.35M. The Plano Texas 75024 based company operating under the Independent Oil & Gas industry has been trending up for the last 52 weeks, with the shares price now 11.04% up for the period and up by 84.16% so far this year. With price target of $3.06 and a 332.56% rebound from 52-week low, Denbury Resources Inc. has plenty of upside potential, making it a hold with a view buy.

Denbury Resources Inc. operates as an independent oil and natural gas company in the United States. The company primarily focuses on enhanced oil recovery utilizing carbon dioxide. It holds properties located in Mississippi, Texas, Louisiana, and Alabama in the Gulf Coast region; and in Montana, North Dakota, and Wyoming in the Rocky Mountain region. As of December 31, 2015, the company had 288.6 million barrels of oil equivalent of estimated proved oil and natural gas reserves. Denbury Resources Inc. was founded in 1951 and is headquartered in Plano, Texas.

CVS Health Corporation (CVS) managed to rebound with the stock climbing 1.12% or $0.86 to close the day at $77.62 on lower than average trading volume of 11.9M shares, compared to its three month average trading volume of 7.82M. The Woonsocket Rhode Island 02895 based company has been outperforming the health care plans companies by -16.9442% for last three months and its recent losses have pulled the stock down -19.17% YTD, versus the health care plans industry which is up 7.27% for the same period. The RSI of 48.96 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.